Updates from The Motley Fool

Latest updates on Provectus Pharmaceuticals, Inc. from Fool.com.

Stock Performance

PVCT vs. S&P 500 | 2 Year Performance
PVCT 1-Day Stock Chart
PVCT 5-Day Stock Chart
PVCT 1-Month Stock Chart
PVCT 3-Month Stock Chart
PVCT 6-Month Stock Chart
PVCT 1-Year Stock Chart
PVCT 2-Year Stock Chart
PVCT 5-Year Stock Chart
View Interactive PVCT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Provectus Pharmaceuticals, Inc..
Current Price: $0.36
Prev Close: $0.35
Open: $0.37
Bid: $0.00
Ask: $0.00
Day's Range: $0.36 - $0.39
52wk Range: $0.32 - $0.84
Volume: 656,283
Avg Vol 291,991
Market Cap: $73.85M
P/E (ttm): -2.41
EPS (ttm): -$0.15
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Provectus Pharmaceuticals, Inc..
CAPS Rating 1 out of 5
28 Outperform
39 Underperform
CAPS All Stars
3 Outperform
29 Underperform

How do you think Provectus Pharmaceuticals, Inc. will perform against the market?

You pick for Provectus Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Provectus Pharmaceuticals, Inc..

A development-stage biopharmaceutical company that is focusing on developing minimally invasive products for the treatment of psoriasis and other topical diseases, and certain forms of cancer.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers